Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1983 Oct;18(4):930–934. doi: 10.1128/jcm.18.4.930-934.1983

Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79.

A P Kendal, T R Cate
PMCID: PMC270933  PMID: 6630472

Abstract

Hemagglutination inhibition (HI) tests against whole virus (WV) influenza B/Singapore/222/79 antigen detected prevaccination serum antibody in only 15 (20%) of 50 predominantly elderly volunteers and fourfold or greater titer rises in only three (6%) after they received 1981-1982 trivalent influenza vaccine containing antigens of this virus. HI titers against ether-treated (ET) B/Singapore/222/79 were about eightfold higher than those against WV antigen and were comparable to microneutralization titers against this virus. The ET HI detected prevaccination antibody in 84%, a postvaccination titer rise in 32%, and a final titer of 80 or higher in 66%. Among 51 additional persons with known or presumed influenza B virus infections early in 1982, ET B/Singapore/222/79 was also more sensitive than WV for serodiagnosis (69 versus 49%), but eight persons with both WV and ET B/Singapore/222/79 HI responses also had an HI titer rise to WV A/Brazil/11/78 (H1N1) antigen. Conversely, among 14 college students with febrile, culture-proven influenza A (H1N1) infections early in 1982, 6 (43%) developed HI titer rises to ET B/Singapore/222/79 with no other serological evidence of influenza B virus infection. Moreover, young adult volunteers with mild experimental influenza A (H1N1) infections also exhibited a 17% (3 of 18) incidence of ET B/Singapore/222/79 HI titer rises, versus none in matched, uninfected volunteers. These data indicate that ET B/Singapore/222/79 virus has increased sensitivity but reduced specificity compared to WV as an HI antigen and that caution is needed in interpretation of a single HI test for serodiagnosis, whether with WV or ET antigen.

Full text

PDF
930

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLIN B. S., MCQUEEN J. L., MINUSE E., DAVENPORT F. M. A METHOD FOR INCREASING THE SENSITIVITY OF THE HEMAGGLUTINATION-INHIBITION TEST WITH EQUINE INFLUENZA VIRUS. Virology. 1963 Dec;21:665–666. doi: 10.1016/0042-6822(63)90244-7. [DOI] [PubMed] [Google Scholar]
  2. Chakraverty P. Comparison of haemagglutination-inhibition and single-radial-haemolysis techniques for detection of antibodies to influenza B virus. Arch Virol. 1980;63(3-4):285–289. doi: 10.1007/BF01315034. [DOI] [PubMed] [Google Scholar]
  3. Coleman M. T., Dowdle W. R. Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus. Bull World Health Organ. 1969;41(3):415–418. [PMC free article] [PubMed] [Google Scholar]
  4. Frank A. L., Puck J., Hughes B. J., Cate T. R. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol. 1980 Sep;12(3):426–432. doi: 10.1128/jcm.12.3.426-432.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hall W. N., Goodman R. A., Noble G. R., Kendal A. P., Steece R. S. An outbreak of influenza B in an elderly population. J Infect Dis. 1981 Oct;144(4):297–302. doi: 10.1093/infdis/144.4.297. [DOI] [PubMed] [Google Scholar]
  6. Hammond G. W., Smith S. J., Noble G. R. Sensitivity and specificity of enzyme immunoassay for serodiagnosis of influenza A virus infections. J Infect Dis. 1980 May;141(5):644–651. doi: 10.1093/infdis/141.5.644. [DOI] [PubMed] [Google Scholar]
  7. ISAACS A., GLEDHILL A. W., ANDREWES C. H. Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1. Bull World Health Organ. 1952;6(3):287–315. [PMC free article] [PubMed] [Google Scholar]
  8. Monto A. S., Maassab H. F. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J Clin Microbiol. 1981 Jan;13(1):54–57. doi: 10.1128/jcm.13.1.54-57.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Turner R., Lathey J. L., Van Voris L. P., Belshe R. B. Serological diagnosis of influenza B virus infection: comparison of an enzyme-linked immunosorbent assay and the hemagglutination inhibition test. J Clin Microbiol. 1982 May;15(5):824–829. doi: 10.1128/jcm.15.5.824-829.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Van Voris L. P., Belshe R. B., Shaffer J. L. Nosocomial influenza B virus infection in the elderly. Ann Intern Med. 1982 Feb;96(2):153–158. doi: 10.7326/0003-4819-96-2-153. [DOI] [PubMed] [Google Scholar]
  11. WERNER G. H., SHARMA R., GOGOLSKI L. Hemagglutinin inhibition with ether-treated antigen as a more sensitive method to measure the immunological response to an Asian influenza virus vaccine. Arch Gesamte Virusforsch. 1960;10:7–18. doi: 10.1007/BF01258764. [DOI] [PubMed] [Google Scholar]
  12. Wright P. F., Bryant J. D., Karzon D. T. Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis. 1980 Apr;141(4):430–435. doi: 10.1093/infdis/141.4.430. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES